Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Globus Medical Inc. (GMED:NYSE), powered by AI.
Globus Medical Inc. is currently trading at $77.52. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Globus Medical Inc. on Alpha Lenz.
Globus Medical Inc.'s P/E ratio is 19.5.
“Globus Medical Inc. trades at a P/E of 19.5 (fair value) with solid ROE of 12.3%. 3Y revenue CAGR of 42.2% highlights clear growth momentum.”
Ask for details →Globus Medical Inc. is a leading medical device company known for its innovation and advancement in musculoskeletal solutions. The company specializes in developing products that address a broad spectrum of orthopedic issues, with a strong emphasis on spinal surgeries. Its extensive portfolio comprises a variety of implants and surgical tools designed to enhance procedures related to the spine, orthopedics, and trauma. By constantly pushing the boundaries of medical technology, Globus Medical Inc. plays a pivotal role in improving surgical outcomes and patient recovery rates. Headquartered in Audubon, Pennsylvania, the company serves a global market, impacting sectors spanning hospitals, clinics, and private practices. Its commitment to research and development drives significant growth and ongoing improvements in healthcare delivery. With a robust network of distribution and a reputation for quality and reliability, Globus Medical Inc. holds a distinguished place within the medical devices industry, contributing to advancing the standards of patient care worldwide. The company’s influence extends across diverse regions, making it a significant player in the global medical device market.
“Globus Medical Inc. trades at a P/E of 19.5 (fair value) with solid ROE of 12.3%. 3Y revenue CAGR of 42.2% highlights clear growth momentum.”
Ask for details →Globus Medical Inc. (ticker: GMED) is a company listed on NYSE in the Healthcare sector (Medical Devices). It has approximately 5,300 employees. Market cap is $10.5B.
The current price is $77.52 with a P/E ratio of 19.49x and P/B of 2.29x.
ROE is 12.29% and operating margin is 18.28%. Annual revenue is $2.9B.